Association among lifestyle, clinical examination, polymorphisms in CDH1 gene and Traditional Chinese Medicine syndrome differentiation of gastric cancer  by Zhang, Junfeng et al.
TOPIC
JTCM |www. journaltcm. com October 15, 2013 |Volume 33 | Issue 5 |
Online Submissions:http://www.journaltcm.com J Tradit Chin Med 2013 October 15; 33(5): 572-579
info@journaltcm.com ISSN 0255-2922
© 2013 JTCM. All rights reserved.
CLINICAL STUDY
Association among lifestyle, clinical examination, polymorphisms
in CDH1 gene and Traditional Chinese Medicine syndrome differen-
tiation of gastric cancer
Junfeng Zhang, Zhen Zhan, Juan Wu, Chunbing Zhang, Yaping Yang, Shujuan Tong, Ruiping Wang, Xuewen
Yang,Wei Dong
aa
Junfeng Zhang, Zhen Zhan, Shujuan Tong,Wei Dong, De-
partment of Pathogen and Immunology, Discipline of Chi-
nese and Western Integrative Medicine, College of Basic
Medicine, Nanjing University of Chinese Medicine, Nanjing
210023, China
JuanWu, Department of Statistics and Preventive Medicine,
Discipline of Chinese and Western Integrative Medicine, Col-
lege of Basic Medicine, Nanjing University of Chinese Medi-
cine, Nanjing 210023, China
Yaping Yang, Department of Traditional Chinese Medicine
Diagnostics, College of Basic Medicine, Nanjing University of
Chinese Medicine, Nanjing 210023, China
Chunbing Zhang, Xuewen Yang, Department of Clinical
Laboratory, First Affiliated Hospital of Nanjing University of
Chinese Medicine, Nanjing 210029, China
Ruiping Wang, Department of Traditional Chinese Medi-
cine Oncology, First Affiliated Hospital of Nanjing University
of Chinese Medicine, Nanjing 210029, China
Supported by National Natural Science Foundation of Chi-
na (30973715 and 81001502), Jiangsu Natural Science Foun-
dation (BK2008461), Priority Academic Program Develop-
ment of Jiangsu Higher Education Institutions (PAPD), Re-
search Fund for the Doctoral Program of Higher Education
of China (20103237110011), Young Teachers in Nanjing Uni-
versity of Chinese Medicine
Correspondence to: Prof. Zhen Zhan, Discipline of Chi-
nese and Western Integrative Medicine, College of Basic
Medicine, Nanjing University of Chinese Medicine, Nanjing
210023, China. zhanzhan5607@sina.com
Telephone: +86-25-85811925
Accepted: April 7, 2013
Abstract
OBJECTIVE: To explore the association among life-
style, clinical examination, polymorphisms in CDH1
gene and Traditional Chinese Medicine (TCM) syn-
drome differentiation of gastric cancer (GC).
METHODS: A hospital-based population of 387 GC
patients was investigated in Jiangsu province. Rele-
vant information regarding lifestyle and clinical ex-
amination were collected by a standard question-
naire. Four known single nucleotide polymor-
phisms (SNPs) in CDH1 were investigated by poly-
merase chain reaction-ligation detection reaction
methods. Statistical analysis was conducted by
SPSS 16.0 software.
RESULTS: The results showed that meal duration
and the status of glutamic pyruvic transaminase
were significantly associated with TCM syndrome
differentiation of GC (both P<0.05). None of the
four SNPs in the E-cadherin (CDH1) gene achieved
significant differences in their distributions among
the nine syndrome types of GC (both P>0.05). How-
ever, significant differences were observed in
rs13689 genotype distributions between several
pairs of syndrome types of GC, suggesting that
rs13689 is correlated with the syndrome differentia-
tion of GC.
CONCLUSION: Integrated analysis of lifestyle, clini-
cal examination and CDH1 gene polymorphisms
can contribute to a better understanding of the GC
syndrome types and may improve the efficacy of in-
terventions by stratifying disease according to TCM
criteria.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Gastric cancer (GC) is one of the most common can-
cers worldwide and the second leading cause of cancer
death; although both the incidence and mortality of
GC have declined in recent years.1,2 There is substantial
geographic variation in the incidence of GC interna-
tionally, with higher rates in East Asian countries such
as Korea, Japan, and China.3 GC, one of the most prev-
alent malignant tumors and the second leading cause
of tumor death in China, has become a public health
priority,4,5 and treatment of GC continues to be a clini-
cal challenge. Although combination therapy for GC is
generally advocated, its adverse effects on the body, es-
pecially on the patient's quality of life, have aroused
the concerns of many researchers. Traditional Chinese
Medicine (TCM) therapy is characterized by "syn-
drome differentiation treatment" and traditional Chi-
nese herbal medicines have been shown to be good at
treating GC and improving the patients' quality of
life.6,7 Correct TCM syndrome differentiation is the
most important principle that guides the prescribing of
Chinese herbal formulae.8 The major advantage of
TCM is that the treatment is based on syndrome differ-
entiation. The phrases "same disease different treat-
ments" and "different diseases same treatment" express
the theory of choosing the specific remedy that will be
most effective for a particular subtype of a disease.
Moreover, TCM categorizes the disease based upon var-
ious dynamic functional aspects.9 However, TCM clini-
cians often have controversial opinions about the syn-
drome types and their connotations based on their dif-
fering clinical experiences, which make it difficult to
draw a consensual conclusion and summary about clin-
ical therapeutic effects.10
It is now generally accepted that the pathogenesis of
GC involves a multi-factorial interaction between envi-
ronmental triggers and genetic susceptibility. It has
been shown that the development of GC is related to
age, gender differences and a number of environmental
factors, such as a salty diet, tobacco smoking, alcohol
consumption and Helicobacter pylori infection.11 In ad-
dition, host factors and genetic alterations also play an
important role in the development and progression of
GC through gene-environment interactions.12,13
It is possible to integrate TCM syndrome differentia-
tion and biomedical diagnosis in modern clinical prac-
tice. Recently many articles have exhibited that TCM
syndromes of GC were correlated with a number of tu-
mor-related molecules, such as estrogen and progester-
one receptors,14 cell adhesion molecule 44,15 carcinoem-
bryonic antigen,16,17 cancer antigen CA72-4,16 E-cad-
herin, C-erbB-2, P53, nm23, anti-intracellular adhe-
sion molecule-1, vascular endothelial growth factor, ki-
nase domain receptor, matrix metalloproteinase-2, and
tissue inhibitor of matrix metalloproteinase-2.18 It is
necessary to explore the components of the TCM syn-
drome of GC and provide a useful reference for stan-
dardizing TCM syndrome differentiation and treat-
ment. In this paper, the association among lifestyle fac-
tors, clinical examination indexes, polymorphisms in
the E-cadherin (CDH1) gene and TCM syndrome dif-
ferentiation of GC.
MATERIALS ANDMETHODS
Study subjects
This research protocol was approved by the institution-
al review board of Jiangsu Province Hospital of TCM.
All subjects were genetically unrelated ethnic Han Chi-
nese. A total of 387 incident GC patients were consecu-
tively recruited from January 2008 to July 2010 in
Nanjing city, Jiangsu province, East China. A standard
questionnaire was administered by trained interviewers
to obtain demographic data and information regarding
GC-related lifestyle factors (eating duration, preference
for salty food, smoking, drinking, etc.) at the time of
clinical examination. A 3-5 mL venous blood sample
was collected from each subject along with a signed
consent form.
Including criteria
Patients included in the study (a) were males or fe-
males over 20 years old but under 80 years old, (b)
were of Han Chinese ethnicity (self-reported), (c) were
local residents of three regions of Jiangsu province for
at least 5 years, (d) had newly histopathologically diag-
nosed primary GC, (e) did not have previous malig-
nant tumors in other organs, (f ) had not had antitu-
mor therapy before recruitment, including chemothera-
py and radiotherapy and (g) did not have complicating
severe heart failure, pulmonary insufficiency and kid-
ney diseases.
Diagnostic criteria
All the patients have been confirmed by pathology.
The standards used for GC syndrome differentiation
were described elsewhere.19 Nine criteria were used for
GC syndrome differentiations: spleen-stomach weak-
ness (SSW), Yin deficiency due to stomach heat
(YDSH), deficiency of both Qi and Yin (DQY), defi-
ciency of both Qi and blood (DQB), liver-stomach dis-
harmony (DLS), dampness-heat-toxin accumulation
(DHT), stagnation of phlegm-muddiness (SPM), ob-
struction of blood stasis (OBS) and others.
Genomic DNA isolation from peripheral blood cells
and genotyping
A commercial blood DNA extraction kit (AxyPrep-96
kit, Axygen, CA, USA) was used to extract genomic
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DNA from the blood samples. The purified DNAs
were stored at －20℃ until they were used for geno-
type testing. The quality of DNA was assessed by aga-
rose gel electrophoresis. Polymerase chain reaction-liga-
tion detection reaction (PCR-LDR) methods were
used for genotyping the four single nucleotide poly-
morphisms (SNPs) (rs13689, rs1801552, rs16260 and
rs17690554) in the CDH1 gene. The SNPs were geno-
typed by Shanghai Biowing Applied Biotechnology
Co., Ltd. (Shanghai, China). The four genotyped
SNPs were identical to our published paper.20
Statistical analyses
All statistical analyses were conducted using SPSS soft-
ware version 16.0 (SPSS Inc., Chicago, IL, USA). The
frequencies of the nine differentiated syndromes of GC
were compared in terms of demographic characteris-
tics, lifestyle factors, clinical examination indexes and
the allele frequencies of each SNP using the χ2 test. Pa-
tient age was analyzed by non-parametric test and t
test. All P values were two-sided and a P<0.05 was con-
sidered statistically significant.
RESULTS
Characteristics of the study subjects
In this paper, a total of 387 GC patients were included
in the current analyses. Gender, age, and syndrome dif-
ferentiation distribution of subjects are shown inTable 1.
The gender proportions among the nine syndrome
types of GC were significantly different (χ2=22.342, P=
0.004), and pair-wise comparisons of gender propor-
tions among the syndrome types were also compared.
The results showed that the gender proportions of six
pairs of syndrome types were significantly different (P<
0.05), i.e., SSW vs OBS (χ2=5.411, P=0.020), YDSH
vs DLS (χ2=8.197, P=0.004), DQY vs DHT (χ2=
4.342, P=0.037), DQY vs OBS (χ2=7.786, P=0.005),
DQB vs OBS (χ2=6.764, P=0.009), DLS vs DHT (χ2=
10.112, P=0.001), and DLS vs OBS (χ2=13.708, P<
0.001). There were no significant differences among
the average ages of the nine syndrome types by two-sid-
ed χ2 test (P>0.05), but it was noted that the average
age of males was prominently higher than that of the
females in the population of SSW (t=2.828, P=0.006)
and SPM (t=2.487, P=0.017).
Relationship between syndrome types and lifestyle
factors
To examine the relationship between syndrome types
and lifestyle factors, the distributions of seven select
lifestyle variables were analyzed by two-sided χ2-test.
The results showed that meal duration was significant-
ly correlated with the syndrome types of GC (P<0.05)
(Table 2).
We also looked for correlations among lifestyle status
and the syndrome types. With respect to insomnia, the
results showed that there were significant differences
between two pairs of syndrome types, i.e., SSW vs DLS
(χ2=8.219, P=0.004), and DLS vs SPM (χ2=4.533, P=
0.033). A significant difference was observed in break-
fast eating behavior between DQB and OBS (χ2=
6.738, P=0.034). For meal duration, there was a signifi-
cant difference between YDSH and DHT (χ2=7.697,
P=0.021). There were significant differences in the per-
centage of participants who smoked between two pairs
Table 1 Common characteristics of the subjects
Notes: SSW: spleen-stomach weakness; YDSH: Yin deficiency due to stomach heat; DQY: deficiency of both Qi and Yin; DQB: deficiency
of both Qi and blood; DLS: liver-stomach disharmony; DHT: dampness-heat-toxin accumulation; SPM: stagnation of phlegm-muddi-
ness; OBS: obstruction of blood stasis. anon-parametric test; btwo-sided χ2-test; ct-test and P<0.05.
Syndrome
types
SSW
YDSH
DQY
DQB
DLS
DHT
SPM
OBS
Others
χ2
P
n (%)
Total
61 (15.8)
59 (15.2)
23 (5.9)
49 (12.7)
43 (11.1)
54 (14.0)
41 (10.6)
35 (9.0)
22 (5.7)
-
-
<60
30 (49.2)
29 (49.2)
13 (56.5)
26 (53.1)
23 (53.5)
24 (44.4)
29 (70.7)
17 (48.6)
16 (72.7)
10.802
0.213a
>60
31 (50.8)
30 (50.8)
10 (43.5)
23 (46.9)
20 (46.5)
30 (55.6)
12 (29.3)
18 (51.4)
6 (27.3)
-
-
Male
41 (67.2)
45 (76.3)
13 (56.5)
31 (63.3)
21 (48.8)
43 (79.6)
31 (75.6)
31 (88.6)
15 (68.2)
22.342
0.004b
Gender [n (%)]
Female
20 (32.8)
14 (23.7)
10 (43.5)
18 (36.7)
22 (51.2)
11 (20.4)
10 (24.4)
4 (11.4)
7 (31.8)
-
-
Age ( xˉ ±s)
Average age
58.3±11.7
61.0±10.6
57.9±13.2
59.8±11.7
59.3±13.2
61.2±12.8
57.3±10.5
60.4±9.3
55.4±13.1
8.472
0.389a
Male
61.2±9.3
61.6±9.9
62.1±6.9
60.5±10.9
61.9±12.8
63.0±12.1
59.5±10.2
61.5±9.1
58.3±11.0
4.200
0.839a
Female
52.6±14.1c
59.0±12.8
52.4±17.4
58.8±13.0
57.0±13.5
57.0±15.0
50.5±8.8c
52.5±7.8
49.3± 6.1
7.989
0.435a
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of syndrome types, i.e., DLS vs OBS (χ2=4.898, P=
0.027), and YDSH vs DLS (χ2=4.423, P=0.035).
When looking at drinking, there were significant differ-
ences between two pairs of syndrome types, i.e., DQB
vs OBS (χ2=10.256, P=0.017), and DQB vs SPM (χ2=
10.451, P=0.015). In contrast, according to regularly
taking meals and preference for salty food, there were
no significant differences between any of the pairs of
syndrome types (all P>0.05).
Relationship between syndrome types and clinical
examination indexes
To examine the relationship between syndrome types
and the results of common clinical examination, the
distributions of nine select clinical examination indexes
were analyzed by two-sided χ2 test. The results showed
that the status of glutamic pyruvic transaminase was
significantly correlated with the syndrome types of GC
(χ2=15.687, P=0.047) (Table 3).
Parallel comparison of the results of clinical examina-
tion between each syndrome type and all remaining
syndrome types were also analyzed. Aspartate amino-
transferase levels were significantly different for three
syndrome types, i.e., DHT vs others (χ2=5.929, P=
0.015), SPM vs others (χ2=5.393, P=0.020), and OBS
vs others (χ2=4.800, P=0.028). For glutamic pyruvic
transaminase, there were significant differences for four
syndrome types, i.e., DHT vs others (χ2=6.532, P=
0.011), SPM vs others (χ2=5.393, P=0.020), SSW vs
DHT (χ2=7.329, P=0.007), and SSW vs SPM (χ2=
4.923, P=0.027). Total protein was significantly differ-
ent between DLS and DHT (χ2=3.946, P=0.047). In
Lifestyle factor
Insomniaa
Regularly taking
mealsb
Eating breakfastc
Meal durationd
Preference for
salty foode
Smokingf
Drinkingg
No
Yes
Often
Occasionally
Seldom
Never
Seldom
Often
Daily
< 10 min
10-20min
> 20 min
Salty
Average
Not well salted
No
Yes
Never
Seldom
Often
Daily
Syndrome type
SSW
46
(90.2)
5
(9.8)
48
(78.7)
7
(11.5)
6
(9.8)
1
(2.0)
4
(8.0)
5
(10.0)
40
(80.0)
37
(60.7)
23
(37.7)
1
(1.6)
30
(49.2)
26
(42.6)
5
(8.2)
33
(54.1)
28
(45.9)
29
(47.5)
17
(27.9)
5
(8.2)
10(16.4)
YDSH
34
(82.9)
7
(17.1)
50
(84.7)
5
(8.5)
4
(6.8)
1
(2.5)
1
(2.5)
6
(15.0)
32
(80.0)
25
(42.4)
32
(54.2)
2
(3.4)
37
(62.7)
20
(33.9)
2
(3.4)
26
(44.1)
33
(55.9)
24
(40.7)
16
(27.1)
9
(15.3)
10(16.9)
DQY
14
(77.8)
4
(22.2)
18
(78.3)
3
(13.0)
2
(8.7)
0
(0.0)
1
(5.3)
1
(5.3)
17
(89.5)
13
(56.5)
5
(21.7)
5
(21.7)
12
(52.2)
6
(26.1)
5
(21.7)
13
(56.5)
10
(43.5)
9
(39.1)
7
(30.4)
2
(8.7)
5(21.7)
DQB
29
(78.4)
8
(21.6)
34
(69.4)
8
(16.3)
7
(14.3)
0
(0.0)
4
(11.1)
7
(19.4)
25
(69.4)
24
(49.0)
24
(49.0)
1
(2.0)
22
(44.9)
21
(42.9)
6
(12.2)
28
(57.1)
21
(42.9)
34
(69.4)
6
(12.2)
2
(4.1)
7(14.3)
DLS
27
(65.9)
14
(34.1)
34
(79.1)
7
(16.3)
2
(4.7)
1
(2.3)
4
(9.3)
8
(18.6)
30
(69.8)
21
(48.8)
17
(39.5)
5
(11.6)
22
(51.2)
16
(37.2)
5
(11.6)
28
(65.1)
15
(34.9)
25
(58.1)
9
(20.9)
6
(14.0)
3(7.0)
DHT
39
(79.6)
10
(20.4)
42
(77.8)
8
(14.8)
4
(7.4)
2
(4.3)
2
(4.3)
8
(17.4)
34
(73.9)
36
(66.7)
18
(33.3)
0
(0.0)
34
(63.0)
17
(31.5)
3
(5.6)
25
(46.3)
29
(53.7)
25
(46.3)
13
(24.1)
7
(13.0)
9(16.7)
SPM
28
(87.5)
4
(12.5)
31
(75.6)
5
(12.2)
5
(12.2)
1
(3.1)
2
(6.2)
4
(12.5)
25
(78.1)
26
(63.4)
14
(34.1)
1
(2.4)
23
(56.1)
14
(34.1)
4
(9.8)
23
(56.1)
18
(43.9)
16
(39.0)
10
(24.4)
8
(19.5)
7(17.1)
OBS
27
(79.4)
7
(20.6)
30
(85.7)
1
(2.9)
4
(11.4)
0
(0.0)
0
(0.0)
2
(6.5)
29
(93.5)
19
(54.3)
14
(40.0)
2
(5.7)
14
(40.0)
19
(54.3)
2
(5.7)
14
(40.0)
21
(60.0)
13
(37.1)
7
(20.0)
7
(20.0)
8(22.9)
Others
14
(82.4)
3
(17.6)
17
(77.3)
3
(13.6)
2
(9.1)
0
(0.0)
3
(17.6)
1
(5.9)
13
(76.5)
11
(50.0)
10
(45.5)
1
(4.5)
9
(40.9)
8
(36.4)
5
(22.7)
14
(63.6)
8
(36.4)
10
(45.5)
4
(18.2)
3
(13.6)
5(22.7)
Notes: SSW: spleen-stomach weakness; YDSH: Yin deficiency due to stomach heat; DQY: deficiency of both Qi and Yin; DQB: deficiency
of both Qi and blood; DLS: liver-stomach disharmony; DHT: dampness-heat-toxin accumulation; SPM: stagnation of phlegm-muddi-
ness; OBS: obstruction of blood stasis. aχ2=10.136, P=0.256; bχ2=9.431, P=0.895; cχ2=19.848, P=0.705; dχ2=35.717, P=0.003; eχ2=21.726,
P=0.152; fχ2=9.392, P=0.310; gχ2=24.618, P=0.427.
Table 2 The relationship between syndrome types and lifestyle factors [n (%)]
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line with hemoglobin, there were significant differenc-
es between two pairs of syndrome types, i.e., DQY vs
DLS (χ2=4.215, P=0.040), and DLS vs OBS (χ2=
4.703, P=0.030). With respect to neutrophilic granulo-
cyte percentage, there were significant differences be-
tween three pairs of syndrome types, i.e., DQY vs DLS
(χ2=4.742, P=0.029), DLS vs others (χ2=7.739, P=
0.005), and SPM vs others (χ2=6.514, P=0.011). How-
ever, with regard to glutamyl GGT, white blood cell
count and glucose, there were no significant differences
between either pair of syndrome types (all P>0.05).
Genotyping distribution and syndrome types of GC
In the present study, no statistical significance was ob-
served in terms of the genotype and allele distributions
of rs13689, rs1801552, rs17690554, and rs16260
among the nine syndrome types of GC (P>0.05) (Ta-
ble 4).
Parallel comparison of the genotype distributions of
the four SNPs in each syndrome type was also ana-
lyzed. For SNP rs13689, there were no significant dif-
ferences among the genotypes TT, TC and CC be-
tween any of the pairs of syndrome types (P>0.05), but
there were significant differences on the basis of the
genotype TT and TC/CC between three pairs of syn-
drome types, i.e., DQB vs OBS (χ2=4.329, P=0.037),
YDSH vs OBS (χ2=3.917, P=0.048), and SSW vs OBS
(χ2=4.022, P=0.045). In light of the SNP rs1801552,
there were no significant differences for the genotypes
CC, TC and TT between any pair of syndrome types
(P>0.05), but it was significantly different between
DLS vs SPM (χ2=4.566, P=0.033) on the basis of the
genotype CC and TC/TT. For SNPs rs17690554 and
rs16260, there were no significant differences between
any pair of syndrome types (P>0.05).
Parallel comparison of the allele distributions of the
four SNPs for each syndrome type was also analyzed.
For the SNP rs13689, there were significant differences
on the basis of the allele T and C for three pairs of syn-
drome types, i.e., OBS vs DQB (χ2=5.327, P=0.021),
OBS vs YDSH (χ2=4.740, P=0.029), and OBS vs
DHT (χ2=4.304, P=0.038). For the SNP rs17690554,
Clinical examination indexe
Aspartate aminotransferasea
Glutamic pyruvic
transaminaseb
Total proteinc
Glutamyl GGTd
White blood celle
Haemoglobinf
Neutrophilicgranulocyte
percentg
Lymphocyte percenth
Glucosei
Normal
Abnormal
Normal
Abnormal
Normal
Abnormal
Normal
Abnormal
Normal
Abnormal
Normal
Abnormal
Normal
Abnormal
Normal
Abnormal
Normal
Abnormal
Syndrome type
SSW
51
(86.4)
8
(13.6)
55
(93.2)
4
(6.8)
40
(67.8)
19
(32.2)
50
(86.2)
8
(13.8)
21
(47.7)
23
(52.3)
11
(25.6)
32
(74.4)
15
(34.1)
29
(65.9)
16
(32.7)
33
(67.3)
53
(91.4)
5
(8.6)
YDSH
50
(84.7)
9
(15.3)
53
(89.8)
6
(10.2)
36
(62.1)
22
(37.9)
48
(82.8)
10
(17.2)
18
(50.0)
18
(50.0)
9
(19.6)
37
(80.4)
11
(31.4)
24
(68.6)
11
(26.2)
31
(73.8)
47
(81.0)
11
(19.0)
DQY
20
(87.0)
3
(13.0)
20
(87.0)
3
(13.0)
13
(56.5)
10
(43.5)
20
(87.0)
3
(13.0)
9
(52.9)
8
(47.1)
6
(40.0)
9
(60.0)
8
(53.3)
7
(46.7)
7
(46.7)
8
(53.3)
21
(91.3)
2
(8.7)
DQB
34
(85.0)
6
(15.0)
35
(87.5)
5
(12.5)
24
(60.0)
16
(40.0)
29
(70.7)
12
(29.3)
13
(48.1)
14
(51.9)
8
(26.7)
22
(73.3)
9
(32.1)
19
(67.9)
10
(32.3)
21
(67.7)
31
(77.5)
9
(22.5)
DLS
36
(87.8)
5
(12.2)
37
(90.2)
4
(9.8)
30
(73.2)
11
(26.8)
33
(80.5)
8
(19.5)
9
(34.6)
17
(65.4)
3
(12.0)
22
(88.0)
4
(19.0)
17
(81.0)
4
(15.4)
22
(84.6)
35
(85.4)
6
(14.6)
DHT
39
(76.5)
12
(23.5)
38
(74.5)
13
(25.5)
27
(52.9)
24
(47.1)
42
(82.4)
9
(17.6)
14
(35.0)
26
(65.0)
9
(25.0)
27
(75.0)
13
(31.0)
29
(69.0)
12
(30.0)
28
(70.0)
41
(80.4)
10
(19.6)
SPM
32
(78.0)
9
(22.0)
32
(78.0)
9
(22.0)
24
(58.5)
17
(41.5)
34
(82.9)
7
(17.1)
12
(44.4)
15
(55.6)
5
(19.2)
21
(80.8)
6
(25.0)
18
(75.0)
5
(18.5)
22
(81.5)
34
(85.0)
6
(15.0)
OBS
28
(80.0)
7
(20.0)
30
(85.7)
5
(14.3)
19
(54.3)
16
(45.7)
29
(82.9)
6
(17.1)
11
(47.8)
12
(52.2)
9
(39.1)
14
(60.9)
7
(33.3)
14
(66.7)
6
(23.1)
20
(76.9)
28
(84.8)
5
(15.2)
Others
21
(100.0)
0
(0.0)
21
(100.0)
0
(0.0)
15
(71.4)
6
(28.6)
17
(81.0)
4
(19.0)
8
(50.0)
8
(50.0)
5
(31.2)
11
(68.8)
7
(43.8)
9
(56.2)
9
(56.2)
7
(43.8)
18
(85.7)
3
(14.3)
Notes: GGT: gamma glutamyl transpeptidase; SSW: spleen-stomach weakness; YDSH: Yin deficiency due to stomach heat; DQY: deficien-
cy of both Qi and Yin; DQB: deficiency of both Qi and blood; DLS: liver-stomach disharmony; DHT: dampness-heat-toxin accumula-
tion; SPM: stagnation of phlegm-muddiness; OBS: obstruction of blood stasis. aχ2=8.578, P=0.379; bχ2=15.687, P=0.047; cχ2=7.014, P=
0.535; dχ2=4.714, P=0.788; eχ2=4.026, P=0.855; fχ2=8.074, P=0.426; gχ2=6.360, P=0.607; hχ2=12.798, P=0.119; iχ2=5.614, P=0.690.
Table 3 The relationship between syndrome types and clinical examination indexes [n (%)]
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there were significant differences on the basis of the al-
lele C and G between the members of three pairs of
syndrome types, i.e., OBS vs DQB (χ2=5.253, P=
0.022), OBS vs DHT (χ2=5.143, P=0.023), and OBS
vs YDSH (χ2=4.080, P=0.043). However, for the SNP
rs1801552 and rs16260, there were no significant dif-
ferences on the basis of the allele distribution for any
pair of syndrome types (all P>0.05).
DISCUSSION
Syndrome differentiation in TCM is the comprehen-
sive analysis of clinical information gained by the four
main diagnostic TCM procedures: observation, listen-
ing, questioning, and pulse analysis. TCM syndrome
differentiation can be used for the further stratification
of the patients' conditions with certain diseases, identi-
fied by orthodox medical diagnosis, which could help
improve the efficacy of the selected intervention. In
modern TCM research, it is possible to integrate syn-
drome differentiation with orthodox medical diagnosis
leading to new scientific findings in overall medical di-
agnosis and treatment.21 Therefore, this study aimed to
provide qualitative and quantitative parameters to pre-
SNPs
rs13689
rs1801552
rs17690554
rs16260
Genotye
TT
TC
CC
TC/CC
T allele
C allele
CC
TC
TT
TC/TT
C allele
T allele
CC
GC
GG
GC/GG
C allele
G allele
AA
CA
CC
CA/CC
C allele
A allele
Syndrome type
SSW
36
(60.0)
23
(38.3)
1
(1.7)
24
(40.0)
95
(79.2)
25
(20.8)
28
(45.9)
25
(41.0)
8
(13.1)
33
(54.1)
81
(66.4)
41
(33.6)
34
(60.7)
21
(37.5)
1
(1.8)
22
(39.3)
89
(79.5)
23
(20.5)
33
(56.9)
24
(41.4)
1
(1.7)
25
(43.1)
90
(77.6)
26
(22.4)
YDSH
33
(60.0)
19
(34.5)
3
(5.5)
22
(40.0)
85
(77.3)
25
(22.7)
23
(40.4)
27
(47.4)
7
(12.3)
34
(59.6)
73
(64.0)
41
(36.0)
34
(64.2)
15
(28.3)
4
(7.5)
19
(35.8)
83
(78.3)
23
(21.7)
29
(50.9)
24
(42.1)
4
(7.0)
28
(49.1)
82
(71.9)
32
(28.1)
DQY
15
(65.2)
8
(34.8)
0
(0.0)
8
(34.8)
38
(82.6)
8
(17.4)
11
(47.8)
7
(30.4)
5
(21.7)
12
(52.2)
29
(63.0)
17
(37.0)
12
(60.0)
8
(40.0)
0
(0.0)
8
(40.0)
32
(80.0)
8
(20.0)
9
(50.0)
7
(38.9)
2
(11.1)
9
(50.0)
25
(69.4)
11
(30.6)
DQB
28
(58.3)
17
(35.4)
3
(6.2)
20
(41.7)
73
(76.0)
23
(24.0)
17
(35.4)
25
(52.1)
6
(12.5)
31
(64.6)
59
(61.5)
37
(38.5)
23
(59.0)
13
(33.3)
3
(7.7)
16
(41.0)
59
(75.6)
19
(24.4)
21
(52.5)
17
(42.5)
2
(5.0)
19
(47.5)
59
(73.8)
21
(26.3)
DLS
24
(61.5)
15
(38.5)
0
(0.0)
15
(38.5)
63
(80.8)
15
(19.2)
20
(48.8)
17
(41.5)
4
(9.8)
21
(51.2)
57
(69.5)
25
(30.5)
26
(63.4)
15
(36.6)
0
(0.0)
15
(36.6)
67
(81.7)
15
(18.3)
22
(56.4)
15
(38.5)
2
(5.1)
17
(43.6)
59
(75.6)
19
(24.4)
DHT
32
(61.5)
17
(32.7)
3
(5.8)
20
(38.5)
81
(77.9)
23
(22.1)
23
(42.6)
22
(40.7)
9
(16.7)
31
(57.4)
68
(63.0)
40
(37.0)
31
(60.8)
16
(31.4)
4
(7.8)
20
(39.2)
78
(76.5)
24
(23.5)
28
(54.9)
19
(37.3)
4
(7.8)
23
(45.1)
75
(73.5)
27
(26.5)
SPM
30
(76.9)
9
(23.1)
0
(0.0)
9
(23.1)
69
(88.5)
9
(11.5)
10
(25.6)
23
(59.0)
6
(15.4)
29
(74.4)
43
(55.1)
35
(44.9)
28
(75.7)
9
(24.3)
0
(0.0)
9
(24.3)
65
(87.8)
9
(12.2)
21
(55.3)
14
(36.8)
3
(7.9)
17
(44.7)
56
(73.7)
20
(26.3)
OBS
28
(80.0)
7
(20.0)
0
(0.0)
7
(20.0)
63
(90.0)
7
(10.0)
10
(28.6)
22
(62.9)
3
(8.6)
25
(71.4)
42
(60.0)
28
(40.0)
28
(80.0)
7
(20.0)
0
(0.0)
7
(20.0)
63
(90.0)
7
(10.0)
22
(66.7)
10
(30.3)
1
(3.0)
11
(33.3)
54
(81.8)
12
(18.2)
Others
17
(77.3)
5
(22.7)
0
(0.0)
5
(22.7)
39
(88.6)
5
(11.4)
7
(31.8)
11
(50.0)
4
(18.2)
15
(68.2)
25
(56.8)
19
(43.2)
17
(77.3)
4
(18.2)
1
(4.5)
5
(22.7)
38
(86.4)
6
(13.6)
11
(55.0)
7
(35.0)
2
(10.0)
9
(45.0)
29
(72.5)
11
(27.5)
χ2
18.397
-
-
10.052
11.782
-
14.602
-
-
9.197
5.278
-
19.692
-
-
8.517
10.324
-
6.664
-
-
2.591
3.564
-
P a
0.301
-
-
0.261
0.161
-
0.554
-
-
0.326
0.728
-
0.234
-
-
0.385
0.243
-
0.979
-
-
0.957
0.894
-
Table 4 Association between CDH1 gene polymorphisms and the syndrome differentiation of GC [n (%)]
Notes: GC: Gastric cancer; CDH1: cadherin-1; SSW: spleen-stomach weakness; YDSH: Yin deficiency due to stomach heat; DQY: defi-
ciency of both Qi and Yin; DQB: deficiency of both Qi and blood; DLS: liver-stomach disharmony; DHT: dampness-heat-toxin accumu-
lation; SPM: stagnation of phlegm-muddiness; OBS: obstruction of blood stasis. aTwo-sided χ2-test.
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cisely and objectively reflect the essence of TCM syn-
drome differentiation and promote the development
and globalization of TCM. In the present study, we
were interested to test whether some lifestyle factors,
clinical examination indexes, and CDH1 gene poly-
morphisms were related with the syndrome type of
GC.
Similar to previous research in China,22,23 our results
showed that men generally develop GC twice as fre-
quently as women, and the male proportions of the
syndrome types YDSH, DHT, SPM and OBS were
more than 300% of the female proportions.
Previous studies have shown that several lifestyle factors,
including regularly taking meals, preference for salty
food, meal duration, smoking status, drinking status,
and eating breakfast, were identified to influence the
risk of GC with gender differences in east China.22,24,25
Our results showed that lifestyle status was closely cor-
related with the syndrome differentiation of GC, most
significantly, meal duration of the nine syndrome types
was distinctly different (χ2=35.717, P=0.003), which
may be an important reason for higher incidence rates
in males than those in females.26 Our findings suggest
that fast eating may play an important role in the for-
mation of DHT.
Conventional clinical examination is widely accepted
as a valid diagnostic in China. To explore the correla-
tion between the status of clinical examination indexes
and the syndrome types of GC, ten kinds of clinical
laboratory indicators were selected to be analyzed by
two-sided c2-test. The status of glutamic pyruvic trans-
aminase was found to be distinctly different in the nine
syndrome types of GC (P<0.05). DHT surprisingly ac-
counted for the highest proportion of abnormal status
(25.5%). It was recently reported that increased serum
enzyme activity was closely related to malignant tu-
mors, such as hepatic carcinoma, breast cancer, lung
cancer, gastric cancer and colon cancer.27 These results
indicate that DHT may be the most malignant and so-
phisticated syndrome type of GC.
The TCM theory considers the tongue to be an outer
extension of the spleen and stomach, and holds that
the tongue coating is produced by gastric Qi through
fumigating so that the status of spleen and stomach
can be exactly and immediately manifested by the ap-
pearance of the tongue , which may reliably direct the
dialectical therapy.28 Tongue appearance was closely re-
lated with the image of gastroscopy29,30 and is of great
importance in guiding the syndrome differentiation of
GC.31 Our previous study found that the differentially
expressed tumor-related genes were one of the root
causes of the change in tongue appearance, such as
tongue fur.32 Among the identified differently ex-
pressed genes, the E-cadherin (CDH1) gene, an impor-
tant tumor suppressor gene located on chromosome
16q22.1, was correlated with TCM syndromes of
GC.18 CDH1-mediated cell-cell adhesion is lost when
many tumors become more malignant.33 Somatic loss
of CDH1 is considered to be a defining feature in inva-
sive lobular breast cancer and GC.34 Down-regulation
of E-cadherin function, due to mutation, deletion,
CpG hypermethylation, or snail-mediated transcrip-
tional repression of the CDH1 gene, have direct conse-
quences for cell shape, polarity, migration and inva-
sion, which are closely related to the development of
cancer.35 Since 1998, an increasing number of germline
mutations have been proposed to cause hereditary
GC.36 And there is currently increasing interest in SNP
mutations in CDH1, given that they could affect the
efficacy of gene transcription and expression. To evalu-
ate the molecular genetics of TCM syndrome type, the
association between four SNPs in the CDH1 gene and
the nine syndrome types of GC were analyzed in this
paper. However, none of the four polymorphisms
achieved significant differences in their distributions
among the nine syndrome types of GC. Of interest are
the significant differences of genotype distributions be-
tween the members of several pairs of syndrome types
of GC. The results suggested that rs13689 was the
most likely to be correlated with the syndrome differen-
tiation of GC. Our latest research found that CA geno-
type of rs16160 and CG genotype of rs17690554 were
associated with the risk of diffuse gastric cancer com-
pared with their wild genotypes,20 but rs17690554 was
not correlated to the syndrome differentiation of GC
in this paper. Of course, owing to the limited number
of each syndrome type of GC, the results needed to be
validated in later studies with larger sample sizes.
To sum up, GC is caused by many well-known factors,
including environmental factors, dietary habits, Helico-
bacter pylori infection and host genetic factors. This pa-
per first observed the association among lifestyle fac-
tors, clinical examination indexes, polymorphisms in
CDH1 gene and TCM syndrome differentiation of
GC. The results indicated that TCM syndrome differ-
entiation may contain richer information than the sin-
gle Western Medicine genetics can detect, which would
further assist in stratification in order to improve the ef-
ficacy of the intervention based on the TCM syndrome
differentiation related clinical trial strategy.
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